4 registrations that name xanthohumol as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 4 registrations
Status
Phase
All 4 registrations
RecruitingNCT06286657
Xanthohumol and Viral Infections (XL)
No phase
University of Vienna
About 100 people
Started Aug 1, 2023
In plain words A study of xanthohumol in people 18 to 70, run by University of Vienna. It plans to enroll about 100 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 70; healthy volunteers accepted. Conditions: Infection Viral.
healthy
BMI >18 kg/m² or < 28kg/m²
The exclusion criteria are on the listing.
What it tests, as registered
Xanthohumol; Placebo
Registered summary
The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.
Where, as registered
No US site; Austria (1).
RecruitingNCT06225258
Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Phase 2
Medical University of Lublin
About 50 people
Started Jan 9, 2023
In plain words A Phase 2 study of xanthohumol in people 18 and older, run by Medical University of Lublin. It plans to enroll about 50 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: Septic Shock; Pneumonia; ARDS.
a septic shock in the early, acute phase,
respiratory insufficiency required mechanical ventilation with PaO2/FiO2 < 150,
bacterial infection,
procalcitonin higher than 5 ng/mL and interleukin 6 higher than 100 pg/mL,
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Xanthohumol
Registered summary
Septic shock (SS) is a life-threatening condition resulting from excessive inflammatory response to bacterial, viral or/and fungal infections. It is associated with dysregulation of the immune system, activation of immune cells, and massive release of cytokines, commonly known as the cytokine storm (CS). The clinical manifestations of SS depend on the initial site of infection. However, the classic symptoms are associated with severe dysfunction of the respiratory and cardiovascular systems, which are observed from the early phase. The full summary is on the listing.
Where, as registered
No US site; Poland (1).
RecruitingNCT06745102
Hop Compounds on the Immune System in Overweight People
No phase
University of Vienna
About 24 people
Started Feb 1, 2024
In plain words A study of xanthohumol in people 18 to 75, run by University of Vienna. It plans to enroll about 24 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 75. Conditions: Inflammatory Response.
BMI 25 - 29,9 kg/m² as well as one or more of the following incipient metabolic diseases:
The aim of the present study is to determine the effect of Iso-alpha Acids and Xanthohumol from hops on the immune response in overweight participants.
Where, as registered
No US site; Austria (1).
RecruitingNCT06286644
Hop Compounds on the Immune System (VH)
No phase
University of Vienna
About 14 people
Started May 30, 2022
In plain words A study of xanthohumol in people 18 to 70, run by University of Vienna. It plans to enroll about 14 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 70; healthy volunteers accepted. Conditions: Inflammatory Response.
The aim of the present study is to determine the effect of Iso-alpha-Acids and Xanthohumol from hops on the immune response of healthy participants over a timeframe of 6 hours.